Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 23  •  04:00PM ET
3.33
Dollar change
-0.23
Percentage change
-6.46
%
IndexRUT P/E0.89 EPS (ttm)3.76 Insider Own17.24% Shs Outstand138.63M Perf Week-2.63%
Market Cap461.62M Forward P/E578.12 EPS next Y0.01 Insider Trans0.00% Shs Float114.72M Perf Month-0.60%
Enterprise Value11.80B PEG- EPS next Q-0.08 Inst Own68.94% Short Float8.74% Perf Quarter14.83%
Income509.00M P/S0.04 EPS this Y-134.28% Inst Trans-2.67% Short Ratio5.83 Perf Half Y24.72%
Sales12.48B P/B- EPS next Y101.41% ROA3.73% Short Interest10.02M Perf YTD6.73%
Book/sh-10.06 P/C1.78 EPS next 5Y- ROE- 52W High4.47 -25.42% Perf Year-5.13%
Cash/sh1.88 P/FCF2.22 EPS past 3/5Y120.07% -2.98% ROIC5.34% 52W Low2.24 48.60% Perf 3Y-49.85%
Dividend Est.- EV/EBITDA7.82 Sales past 3/5Y0.74% 1.15% Gross Margin8.67% Volatility8.49% 6.14% Perf 5Y-61.19%
Dividend TTM- EV/Sales0.95 EPS Y/Y TTM197.65% Oper. Margin8.67% ATR (14)0.20 Perf 10Y-72.37%
Dividend Ex-DateDec 13, 2012 Quick Ratio1.32 Sales Y/Y TTM-1.19% Profit Margin4.08% RSI (14)51.39 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio1.46 EPS Q/Q251.40% SMA202.29% Beta2.10 Target Price3.65
Payout0.00% Debt/Eq- Sales Q/Q-4.87% SMA502.37% Rel Volume1.09 Prev Close3.56
Employees57000 LT Debt/Eq- EarningsFeb 18 AMC SMA2001.52% Avg Volume1.72M Price3.33
IPOJun 09, 2000 Option/ShortYes / Yes EPS/Sales Surpr.80.28% -1.00% Trades Volume1,889,947 Change-6.46%
Date Action Analyst Rating Change Price Target Change
Jul-24-25Downgrade Jefferies Buy → Hold $3
Nov-25-24Downgrade Wells Fargo Equal Weight → Underweight $5 → $2.50
Nov-22-24Downgrade Raymond James Mkt Perform → Underperform
Mar-06-24Initiated Barclays Equal Weight $3
Jun-17-22Initiated Loop Capital Hold $5
Jun-15-22Downgrade BofA Securities Buy → Neutral $7.50 → $5.50
Mar-29-22Initiated Wells Fargo Equal Weight $12
Jan-10-22Resumed Citigroup Buy $16 → $18
Dec-13-21Upgrade BofA Securities Underperform → Buy $14 → $16
Sep-24-21Initiated UBS Neutral $12.50
Feb-20-26 11:00AM
03:30AM
Feb-19-26 06:02PM
12:34PM
08:30AM
07:00PM Loading…
Feb-18-26 07:00PM
05:45PM
05:00PM
04:15PM
Feb-17-26 09:15AM
Feb-11-26 07:55AM
Feb-04-26 11:00AM
Feb-02-26 04:15PM
09:00AM
09:00AM
09:38AM Loading…
Jan-22-26 09:38AM
Jan-21-26 03:39AM
Jan-20-26 04:15PM
Jan-15-26 03:10PM
Jan-09-26 05:12AM
Jan-08-26 09:34AM
Dec-31-25 11:24AM
Dec-15-25 04:15PM
Dec-11-25 03:59AM
Dec-10-25 04:15PM
Dec-09-25 11:38AM
Dec-04-25 02:17AM
Dec-02-25 04:15PM
Nov-24-25 08:42AM
Nov-07-25 11:36AM
11:00AM Loading…
Nov-05-25 11:00AM
Nov-03-25 04:41AM
Oct-31-25 10:37AM
Oct-30-25 04:30PM
01:35PM
Oct-27-25 05:49AM
02:08AM
Oct-24-25 05:30PM
05:02PM
12:34PM
Oct-23-25 06:00PM
05:25PM
04:25PM
04:15PM
09:26AM
Oct-22-25 09:44AM
Oct-16-25 10:00AM
03:28AM
Oct-15-25 10:18AM
Oct-09-25 11:00AM
Aug-29-25 01:15PM
Aug-27-25 11:00AM
Aug-26-25 08:00AM
Aug-11-25 05:26PM
08:00AM
Aug-08-25 06:07AM
Aug-07-25 12:28PM
Aug-01-25 11:40AM
Jul-31-25 09:00AM
Jul-28-25 06:40PM
06:35PM
07:50AM
07:45AM
Jul-25-25 08:30AM
07:48AM
03:20AM
Jul-24-25 11:33AM
05:00AM
Jul-23-25 05:55PM
04:47PM
04:16PM
04:15PM
10:04AM
05:46AM
Jul-22-25 04:15PM
09:37AM
03:28AM
Jul-21-25 09:23AM
Jul-09-25 11:00AM
10:19AM
Jul-01-25 09:00AM
May-23-25 11:30AM
May-14-25 11:00AM
May-07-25 08:00AM
May-05-25 07:42AM
May-01-25 01:40AM
Apr-29-25 01:21PM
05:20AM
Apr-28-25 10:58AM
Apr-25-25 04:52AM
Apr-24-25 05:19PM
04:48AM
Apr-23-25 07:30PM
06:05PM
05:06PM
04:32PM
04:31PM
04:15PM
Apr-21-25 10:00AM
Apr-16-25 10:25AM
Community Health Systems, Inc. engages in the provision of general and specialized healthcare services and outpatient services. The company was founded in March 1985 and is headquartered in Franklin, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ely James S. IIIDirectorDec 31 '25Option Exercise0.002,8820362,281Dec 31 04:36 PM
Tim Hingtgenformer CEODec 09 '25Proposed Sale3.3866,666225,664Dec 09 02:34 PM
Tim Hingtgenformer CEOOct 28 '25Proposed Sale4.18532,8132,226,625Oct 28 01:23 PM
Brooks Susan WDirectorJun 01 '25Option Exercise0.005,894058,100Jun 02 04:36 PM
Hingtgen TimCEOMar 01 '25Option Exercise0.0033,60001,267,588Mar 03 06:06 PM
MEDLEY MARK BRegional PresidentMar 01 '25Option Exercise0.0010,5000119,319Mar 03 06:05 PM
MASON AUSTEN DRegional PresidentMar 01 '25Option Exercise0.0010,5000117,500Mar 03 06:05 PM
CAMPBELL CHAD ARegional PresidentMar 01 '25Option Exercise0.0010,5000125,787Mar 03 06:04 PM
STOCKTON KEVIN AEVP, Operations & DevelopmentMar 01 '25Option Exercise0.0010,5000142,232Mar 03 06:04 PM
Pitt Justin DPres,Chief Legal&Admin OfficerMar 01 '25Option Exercise0.006,3000214,416Mar 03 06:04 PM
Johnson Jason KSVP & CAOMar 01 '25Option Exercise0.005,2500154,593Mar 03 06:03 PM
HAMMONS KEVIN JPresident and CFOMar 01 '25Option Exercise0.0025,2000589,566Mar 03 06:03 PM
BENET MIGUEL SPresident and CMOMar 01 '25Option Exercise0.003,150058,150Mar 03 06:02 PM
SMITH WAYNE TDirectorMar 01 '25Option Exercise0.0030,24005,236,979Mar 03 06:02 PM
Williams Hubert JamesDirectorMar 01 '25Option Exercise0.0036,5560161,268Mar 03 06:01 PM
Hirsch Elizabeth TDirectorMar 01 '25Option Exercise0.0036,5560111,464Mar 03 05:59 PM
FRY JOHN ADirectorMar 01 '25Option Exercise0.0036,5560218,371Mar 03 05:58 PM
Ely James S. IIIDirectorMar 01 '25Option Exercise0.0036,5560359,399Mar 03 05:58 PM
DINKINS MICHAELDirectorMar 01 '25Option Exercise0.0036,5560195,220Mar 03 05:57 PM
CLERICO JOHN ADirectorMar 01 '25Option Exercise0.0036,5560318,168Mar 03 05:57 PM
Brooks Susan WDirectorMar 01 '25Option Exercise0.0030,662052,206Mar 03 05:56 PM
Last Close
Feb 23  •  04:00PM ET
103.39
Dollar change
-0.04
Percentage change
-0.04
%
EXAS Exact Sciences Corp daily Stock Chart
Index- P/E- EPS (ttm)-1.10 Insider Own1.56% Shs Outstand190.80M Perf Week0.15%
Market Cap19.74B Forward P/E82.27 EPS next Y1.26 Insider Trans-0.86% Shs Float187.90M Perf Month1.00%
Enterprise Value21.31B PEG- EPS next Q-0.19 Inst Own86.27% Short Float3.54% Perf Quarter19.97%
Income-207.95M P/S6.08 EPS this Y124.70% Inst Trans-7.45% Short Ratio1.85 Perf Half Y121.49%
Sales3.25B P/B8.22 EPS next Y362.58% ROA-3.39% Short Interest6.65M Perf YTD1.80%
Book/sh12.58 P/C20.46 EPS next 5Y- ROE-8.66% 52W High103.54 -0.14% Perf Year109.89%
Cash/sh5.05 P/FCF55.32 EPS past 3/5Y32.20% 27.36% ROIC-4.25% 52W Low38.81 166.39% Perf 3Y67.76%
Dividend Est.- EV/EBITDA323.31 Sales past 3/5Y15.92% 16.84% Gross Margin69.69% Volatility0.23% 0.31% Perf 5Y-25.46%
Dividend TTM- EV/Sales6.56 EPS Y/Y TTM80.14% Oper. Margin-4.79% ATR (14)0.36 Perf 10Y1512.95%
Dividend Ex-Date- Quick Ratio2.17 Sales Y/Y TTM17.69% Profit Margin-6.40% RSI (14)72.75 Recom2.88
Dividend Gr. 3/5Y- - Current Ratio2.43 EPS Q/Q90.29% SMA200.47% Beta1.41 Target Price104.00
Payout- Debt/Eq1.06 Sales Q/Q23.12% SMA501.08% Rel Volume0.39 Prev Close103.43
Employees7200 LT Debt/Eq1.04 EarningsFeb 13 AMC SMA20048.25% Avg Volume3.60M Price103.39
IPOJan 31, 2001 Option/ShortYes / Yes EPS/Sales Surpr.-317.05% 2.03% Trades Volume1,526,464 Change-0.04%
Date Action Analyst Rating Change Price Target Change
Jan-20-26Downgrade Mizuho Outperform → Neutral $105
Jan-05-26Downgrade Evercore ISI Outperform → In-line $105
Apr-10-25Initiated Mizuho Outperform $60
Mar-13-25Initiated RBC Capital Mkts Sector Perform $52
Jan-23-25Initiated Barclays Overweight $70
Aug-28-24Initiated Wells Fargo Overweight $75
Jun-27-24Initiated Scotiabank Sector Outperform $70
Jun-03-24Resumed Jefferies Buy $75
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Feb-23-26 12:07PM
Feb-20-26 04:05PM
11:32AM
Feb-19-26 09:50AM
08:16AM
10:57PM Loading…
Feb-16-26 10:57PM
11:40AM
Feb-13-26 05:15PM
04:21PM
04:05PM
Feb-12-26 01:04PM
Feb-09-26 11:01AM
Feb-08-26 11:04PM
Feb-06-26 05:41PM
Feb-03-26 02:32PM
09:03AM Loading…
09:03AM
08:30AM
Feb-02-26 12:05PM
Jan-28-26 06:46AM
Jan-27-26 11:40AM
07:46AM
Jan-26-26 06:40AM
Jan-22-26 04:02PM
04:01PM
02:16PM
09:48AM
08:53AM
Jan-20-26 08:47AM
07:55AM
Jan-13-26 01:00PM
07:51AM Loading…
Jan-12-26 07:51AM
Jan-09-26 02:24PM
Jan-08-26 04:30PM
12:48PM
12:21PM
Jan-07-26 12:31PM
11:52AM
11:49AM
Jan-06-26 11:18AM
11:00AM
Jan-04-26 11:32PM
Dec-31-25 07:25AM
Dec-30-25 07:32AM
07:32AM
Dec-26-25 01:48PM
Dec-16-25 02:09PM
Dec-15-25 02:59PM
Dec-11-25 05:30PM
Dec-10-25 11:35PM
Dec-08-25 01:35AM
Dec-05-25 09:41AM
Dec-03-25 11:30AM
Dec-02-25 04:54AM
Dec-01-25 12:33PM
Nov-30-25 02:05AM
Nov-28-25 12:41PM
Nov-25-25 09:36AM
09:17AM
01:33AM
Nov-24-25 04:35PM
09:41AM
09:20AM
Nov-23-25 10:30PM
Nov-21-25 09:10AM
07:32AM
06:30AM
04:50AM
03:35AM
Nov-20-25 07:50PM
07:43PM
06:29PM
05:06PM
05:05PM
04:44PM
04:23PM
04:15PM
04:14PM
03:31PM
03:08PM
03:03PM
03:01PM
02:47PM
01:36PM
01:02PM
12:01PM
11:51AM
11:32AM
10:21AM
09:41AM
09:31AM
09:26AM
08:43AM
08:09AM
07:46AM
07:46AM
07:30AM
06:27AM
Nov-19-25 07:21PM
04:57PM
04:31PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORVILLE JACOB AEVP, GM, ScreeningDec 23 '25Option Exercise0.0073,080069,511Dec 30 04:30 PM
Baranick BrianEVP, GM, Precision OncologyDec 23 '25Option Exercise0.0073,080066,487Dec 30 04:30 PM
Condella SarahEVP, Human ResourcesDec 23 '25Option Exercise0.0047,2080118,059Dec 30 04:30 PM
Herriott JamesSVP, General Counsel & SecDec 23 '25Option Exercise0.0033,780032,934Dec 30 04:30 PM
Bloomer AaronEVP, Chief Financial OfficerDec 23 '25Option Exercise0.0063,099059,571Dec 30 04:30 PM
ORVILLE JACOB AEVP, GM, ScreeningNov 19 '25Sale75.005,000375,00023,237Nov 21 05:30 PM
Herriott JamesSVP, General Counsel & SecNov 19 '25Sale70.001,00070,00011,585Nov 21 05:30 PM
ORVILLE JACOB AOfficerNov 19 '25Proposed Sale75.005,000375,000Nov 19 03:11 PM
Herriott JamesOfficerNov 19 '25Proposed Sale70.001,00070,000Nov 19 12:04 PM
Herriott JamesSVP, General Counsel & SecNov 04 '25Sale70.081,500105,12012,585Nov 06 05:29 PM
Baranick BrianEVP, GM, Precision OncologyNov 04 '25Sale70.082,858200,28922,368Nov 06 05:29 PM
Baranick BrianOfficerNov 04 '25Proposed Sale70.082,858200,289Nov 04 10:25 AM
Herriott JamesOfficerNov 04 '25Proposed Sale70.081,500105,120Nov 04 10:22 AM
Zanotti Katherine SDirectorOct 24 '25Sale65.0012,000780,00060,759Oct 27 08:35 PM
Zanotti Katherine SDirectorOct 24 '25Proposed Sale65.0012,000780,000Oct 24 11:08 AM
Herriott JamesSVP, General Counsel & SecOct 09 '25Sale60.001,50090,00014,085Oct 10 05:27 PM
Doyle James EdwardDirectorOct 09 '25Sale60.002,000120,00057,962Oct 10 05:25 PM
Herriott JamesOfficerOct 09 '25Proposed Sale60.001,50090,000Oct 09 11:23 AM
Doyle James EdwardDirectorOct 09 '25Proposed Sale60.002,000120,000Oct 09 11:18 AM
Doyle James EdwardDirectorAug 13 '25Sale42.021,48562,40059,962Aug 14 04:30 PM
Doyle James EdwardDirectorAug 13 '25Proposed Sale42.021,48562,400Aug 13 10:09 AM
ORVILLE JACOB AEVP, GM, ScreeningAug 05 '25Option Exercise0.005,350030,752Aug 07 05:30 PM
Baranick BrianEVP, GM, Precision OncologyAug 05 '25Option Exercise0.005,350027,943Aug 07 05:30 PM
Sebelius KathleenFormer DirectorJul 16 '25Proposed Sale53.118,164433,605Jul 16 04:22 PM
Zanotti Katherine SDirectorJun 13 '25Sale53.203,207170,61272,759Jun 16 05:30 PM
Zanotti Katherine SDirectorJun 13 '25Proposed Sale53.203,207170,612Jun 13 09:50 AM
Bloomer AaronEVP, Chief Financial OfficerApr 15 '25Option Exercise0.0024,460019,340Apr 17 04:30 PM
Conroy Kevin TPresident and CEOMar 07 '25Option Exercise22.3866,7231,493,2611,203,269Mar 10 05:00 PM
Herriott JamesSVP, General Counsel & SecFeb 28 '25Option Exercise0.004,265016,339Mar 04 04:48 PM
Conroy Kevin TPresident and CEOFeb 28 '25Option Exercise0.0040,31001,146,965Mar 04 04:47 PM
Baranick BrianEVP, GM, Precision OncologyFeb 28 '25Option Exercise0.009,673025,106Mar 04 04:44 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 28 '25Option Exercise0.009,673027,728Mar 04 04:40 PM
Condella SarahEVP, Human ResourcesFeb 28 '25Option Exercise0.007,738084,399Mar 04 04:37 PM
Condella SarahEVP, Human ResourcesFeb 25 '25Option Exercise0.003,954080,297Feb 26 08:00 PM
Baranick BrianEVP, GM, Precision OncologyFeb 25 '25Option Exercise0.003,954019,841Feb 26 08:00 PM
Herriott JamesSVP, General Counsel & SecFeb 25 '25Option Exercise0.001,647013,738Feb 26 08:00 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 25 '25Option Exercise0.003,954022,136Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 25 '25Option Exercise0.0013,18001,121,378Feb 26 08:00 PM